US Bancorp
MBX icon

US Bancorp’s MBX Biosciences MBX Stock Holding History

US Bancorp’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96K Sell
108
-176
-62% -$6.15K ﹤0.01% 3602
2026
Q1 		$8.48K Sell
284
-28
-9% -$952 ﹤0.01% 3415
2025
Q4 		$9.8K Sell
312
-25
-7% -$607 ﹤0.01% 3337
2025
Q3 		$5.9K Hold
337
– – ﹤0.01% 3487
2025
Q2 		$3.84K Buy
337
+7
+2% +$71 ﹤0.01% 3714
2025
Q1 		$2.44K Buy
+330
New +$3.49K ﹤0.01% 3832

Other funds holding MBX

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Polar Capital Holdings
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

US Bancorp's MBX Position: Q2 2026 in Review

US Bancorp reduced its MBX Biosciences (MBX) stake by 62% in Q2 2026, selling an estimated $6.15K and leaving 108 shares worth $5.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3602.

US Bancorp first reported a position in MBX in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.8K in Q4 2025. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • US Bancorp held 108 shares of MBX Biosciences worth $5.96K as of Q2 2026.
  • US Bancorp sold 176 MBX Biosciences shares in Q2 2026, an estimated $6.15K.
  • MBX Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3602 holding.
  • US Bancorp first reported a position in MBX Biosciences in Q1 2025 and has held it in 6 quarters since.
  • US Bancorp's MBX Biosciences position peaked at $9.8K in Q4 2025.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.